RVMD: Revolution Medicines Inc Kompaniya qiymatining sof foydaga nisbati

Revolution Medicines Inc - RVMD emitenti grafik logotipi

Revolution Medicines (RVMD) kompaniyasining median P/E ko'rsatkichi biznesning baholanish tendentsiyasini aks ettiradi, bunda -20.00 joriy metrika darajasini ifodalaydi. Turli onkologik dori vositalari bo'yicha tadqiqotlarni diversifikatsiya qilish alohida testlarning muvaffaqiyatsizligi bilan bog'liq xatarlarni minimallashtiradi. Noyob inhibitorlarning ishlab chiqilishi kelajakda monopol narx belgilash imkoniyatini ta'minlaydi. Tashqi moliyalashtirishga bog'liqlikka qaramay, kompaniyaning ilmiy ishlanmalari qiymati bozor sikllaridan qat'i nazar barqaror qolmoqda.

Narx-foyda koeffitsiyenti: Revolution Medicines (RVMD) 04.07.2022 - 16.11.2026 uchun

Revolution Medicines Inc (RVMD) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning har tomonlama tahlili:Revolution Medicines, Inc. - RVMD
Revolution Medicines, Inc. yetakchi tovari

Revolution Medicines uzoq muddatli maqsadli onkologik yechimlarni ishlab chiqishga ixtisoslashgan bo'lib, bu ushbu kasalliklarning surunkli tabiati tufayli barqaror daromad oqimini ta'minlaydi. Kompaniyaning joriy P/E koeffitsiyentini tahlil qilish orqali investor biznesning bozor qiymati va uning yillik foydasi o'rtasidagi bog'liqlikni baholaydi, bu esa aktivning haddan tashqari qimmat baholanganlik darajasini aniqlash va aksiyalar narxidagi tez-tez uchraydigan tebranishlar paytida likvidlilik risklarini o'z vaqtida aniqlash imkonini beradi.

Muhim raqobatchilar

ONC: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti HALO (Halozyme Inc.)|AAPG (Ascentage) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori CGON (cgoncology.com)|URGN - Narx-foyda koeffitsiyenti|BCAX: Narx-foyda koeffitsiyenti|PSNL - P/E multiplikatori|Erasca Corp (ERAS) - Narxning foydaga nisbati|Delcath - Kompaniya qiymatining sof foydaga nisbati|YMAB (Y-mAbs Therapeutics Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Aura Biosciences, Inc. AURA|P/E multiplikatori CADL|P/E multiplikatori Accuray (ARAY)|Narxning foydaga nisbati SELLAS Life Sciences Group Inc. SLS|ACTU - Narx-foyda koeffitsiyenti|CTOR: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning foydaga nisbati Fate Therapeutics Corp (FATE)|Narx-foyda koeffitsiyenti WHWK|Narx-foyda multiplikatori TCRX (TScan Therapeutics, Inc.)|P/E multiplikatori CSBR|XBIT - Kapitalizatsiyaning foydaga nisbati|CEL-SCI Corporation - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati OSTX|radiopharmtheranostics.com - P/E multiplikatori|ARTV: Narxning foydaga nisbati|ANL (adlainortye.com) - Narx-foyda koeffitsiyenti|VERU - Biznesning o‘zini qoplash muddati|TPST (Tempest Therapeutics, Inc.) - P/E multiplikatori|P/E multiplikatori xiliotx.com|Narxning foydaga nisbati Enochian BioSciences (RENB)|Narxning foydaga nisbati MURA (Mural Oncology PLC)|Narxning foydaga nisbati Kairos Pharma Ltd KAPA|P/E multiplikatori OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - P/E multiplikatori|Biznesning o‘zini qoplash muddati Curis CRIS|APLM: P/E multiplikatori|Narx-foyda koeffitsiyenti Tharimmune, Inc.|ADVB (Advanced Biomed) - P/E multiplikatori|Genprex - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Kapitalizatsiyaning foydaga nisbati|PPBT: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati AONC (American Oncology Network, Inc.)|BeOne Medicines (BGNE) - Narxning foydaga nisbati|Checkpoint Therapeutics, Inc (CKPT) - P/E multiplikatori|Narxning foydaga nisbati Elevation Oncology, Inc.|ICAD: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati ikenaoncology.com (IKNA)|Narxning foydaga nisbati NTBL (Notable Labs, Ltd.)|P/E multiplikatori VIRX (viracta.com)|MOR - Narx-foyda koeffitsiyenti|NAYA - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati AAPGV